Thomas Herold Selected Research

Thomas Herold Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2014
6	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
4	Adenocarcinoma 09/2021 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2018
3	Malignant Mesothelioma 10/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 01/2018
2	Necrosis 10/2020 - 01/2019
2	Anaplastic Thyroid Carcinoma 10/2020 - 06/2017
2	Adenocarcinoma of Lung 01/2020 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
2	Urachal cancer 01/2018 - 12/2017
2	Carcinoma (Carcinomatosis) 12/2017 - 06/2017
2	Hemorrhage 05/2008 - 03/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Water Intoxication 01/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2019
1	Mesothelioma 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Microsatellite Instability 10/2018
1	Carcinogenesis 01/2018
1	Circulating Neoplastic Cells 05/2017
1	medullary Thyroid cancer 01/2016
1	Pain (Aches) 08/2010
1	Low Back Pain (Lumbago) 08/2010
1	Sacroiliitis 08/2010
1	Fibrosis (Cirrhosis) 05/2008
1	Aortic Diseases 03/2006
1	Pathologic Constriction (Stenosis) 05/2005

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2017
3	Anaplastic Lymphoma KinaseIBA 09/2021 - 01/2017
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2020 - 05/2017
3	ErbB Receptors (EGF Receptor)IBA 11/2018 - 01/2018
2	PlatinumIBA 01/2022 - 09/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2017
2	Pemetrexed (MTA)FDA Link 01/2021 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2020
2	EnzymesIBA 10/2020 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2019 - 02/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 02/2017
1	brigatinibIBA 09/2021
1	serum P-component (CIt)IBA 09/2021
1	alectinibIBA 09/2021
1	Tyrosine Kinase InhibitorsIBA 09/2021
1	lorlatinibIBA 09/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	VimentinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Cetuximab (Erbitux)FDA Link 12/2020
1	Growth Factor ReceptorsIBA 11/2020
1	MetallothioneinIBA 10/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2020
1	Histone Deacetylase InhibitorsIBA 10/2020
1	CrizotinibIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2019
1	olaparibIBA 01/2019
1	AsbestosIBA 01/2019
1	Biological ProductsIBA 01/2019
1	AfatinibIBA 11/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2017
1	TensinsIBA 05/2017
1	PhosphoproteinsIBA 02/2017
1	Pharmaceutical PreparationsIBA 02/2017
1	Sorafenib (BAY 43-9006)FDA Link 02/2017
1	vandetanib (ZD6474)IBA 01/2016
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2014
1	GadoliniumIBA 08/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2010
1	Triamcinolone (Aristocort)FDA Link 08/2010
1	Irbesartan FDA LinkGeneric 05/2008
1	Angiotensin Receptor AntagonistsIBA 05/2008
1	Propranolol (Inderal)FDA LinkGeneric 05/2008
1	SodiumIBA 05/2008
1	Angiotensin IIIBA 05/2008

Therapy/Procedure

15	Therapeutics 01/2022 - 05/2005
6	Drug Therapy (Chemotherapy) 11/2021 - 01/2017
2	Immunotherapy 10/2020 - 01/2018
1	Genomic Medicine 11/2021
1	Chemoradiotherapy 06/2017
1	Injections 08/2010
1	Stents 03/2008
1	Aftercare (After-Treatment) 03/2006